Portal de Periódicos da CAPES

Evaluation of Three Commercially Available Japanese Encephalitis Virus IgM Enzyme-Linked Immunosorbent Assays

2010; American Society of Tropical Medicine and Hygiene; Volume: 83; Issue: 5 Linguagem: Inglês

10.4269/ajtmh.2010.10-0212

1476-1645

Jaimie Robinson, David Featherstone, Vasanthapuram Ravi, Brad J. Biggerstaff, Anita Desai, Nalini Ramamurty, Atique Iqbal Chowdhury, Hardeep Sandhu, Kathleen F. Cavallaro, Barbara W. Johnson,

Vector-borne infectious diseases

We evaluated performance of three commercial Japanese encephalitis virus (JEV) IgM antibody capture enzyme-linked immunosorbent assay (MAC ELISA) kits with a panel of serological specimens collected during a surveillance project of acute encephalitis syndrome in India and acute meningitis and encephalitis syndrome in Bangladesh. The serum and cerebral spinal fluid specimens had been referred to the Centers for Disease Control and Prevention (CDC) for confirmatory testing. The CDC results and specimen classifications were considered the reference standard. All three commercial kits had high specificity (95–99.5%), but low sensitivities, ranging from 17–57%, with both serum and cerebrospinal fluid samples. Specific factors contributing to low sensitivity compared with the CDC ELISA could not be determined through further analysis of the limits and dilution end points of IgM detection.